MAS
EW icon

Meeder Advisory Services’s Edwards Lifesciences EW Stock Holding History

Meeder Advisory Services’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$857K Buy
10,701
+206
+2% +$17K 0.04% 305
2025
Q4 		$895K Buy
10,495
+3,686
+54% +$302K 0.04% 295
2025
Q3 		$530K Sell
6,809
-2,479
-27% -$194K 0.02% 382
2025
Q2 		$726K Buy
9,288
+1,148
+14% +$85.6K 0.04% 313
2025
Q1 		$590K Sell
8,140
-646
-7% -$46.2K 0.04% 327
2024
Q4 		$650K Sell
8,786
-329
-4% -$23K 0.04% 301
2024
Q3 		$602K Sell
9,115
-818
-8% -$59.4K 0.04% 303
2024
Q2 		$918K Buy
9,933
+2,813
+40% +$249K 0.06% 237
2024
Q1 		$680K Buy
7,120
+112
+2% +$9.41K 0.07% 241
2023
Q4 		$534K Sell
7,008
-1,170
-14% -$81.4K 0.06% 259
2023
Q3 		$567K Sell
8,178
-1,808
-18% -$145K 0.07% 233
2023
Q2 		$942K Buy
9,986
+514
+5% +$44.7K 0.1% 164
2023
Q1 		$784K Buy
9,472
+409
+5% +$32.1K 0.09% 200
2022
Q4 		$676K Buy
+9,063
New +$698K 0.09% 214

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Meeder Advisory Services's EW Position: Q1 2026 in Review

Meeder Advisory Services increased its Edwards Lifesciences (EW) stake by 2% in Q1 2026, buying an estimated $17K and bringing the position to 10,701 shares worth $857K. The position accounts for 0.04% of the portfolio, ranked #305.

Meeder Advisory Services first reported a position in EW in Q4 2022 and has held it in 14 quarters since. The position peaked at $942K in Q2 2023. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Meeder Advisory Services held 10,701 shares of Edwards Lifesciences worth $857K as of Q1 2026.
  • Meeder Advisory Services bought 206 Edwards Lifesciences shares in Q1 2026, an estimated $17K.
  • Edwards Lifesciences made up 0.04% of Meeder Advisory Services's portfolio in Q1 2026, its #305 holding.
  • Meeder Advisory Services first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 14 quarters since.
  • Meeder Advisory Services's Edwards Lifesciences position peaked at $942K in Q2 2023.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.